| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | 2.16.840.1.113762.1.4.1213.109 |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1213.109/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1213.109 |
| Version | 20231215 |
| Status | active |
| Date | 2023-12-15T19:18:20-05:00 |
| Name | OralAnticoagulantIngredientsAndRiskOfGIBleeding |
| Title | Oral Anticoagulant Ingredients and Risk of GI Bleeding |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for oral anticoagulants at an ingredietn level and identified products containing those: warfarin, apixaban, edoxaban, dabigatran and rivaroxaban),(Data Element Scope: This value uses the corresponding RxCui for each ingredient of interest),(Inclusion Criteria: Includes concepts that describe oral anticoagulants),(Exclusion Criteria: Excludes concepts that describe branded and non-prescribable oral anticoagulants) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR